Growth Metrics

Cannabis Suisse (CSUI) Cost of Revenue (2016 - 2025)

Cannabis Suisse has reported Cost of Revenue over the past 9 years, most recently at $7356.0 for Q1 2025.

  • Quarterly Cost of Revenue rose 6.98% to $7356.0 in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $7356.0 through Nov 2025, down 76.29% year-over-year, with the annual reading at $22068.0 for FY2025, 26.6% down from the prior year.
  • Cost of Revenue was $7356.0 for Q1 2025 at Cannabis Suisse, roughly flat from $7356.0 in the prior quarter.
  • Over five years, Cost of Revenue peaked at $65703.0 in Q2 2021 and troughed at $1734.0 in Q4 2021.
  • The 5-year median for Cost of Revenue is $6875.5 (2023), against an average of $10872.7.
  • Year-over-year, Cost of Revenue tumbled 97.36% in 2022 and then surged 296.42% in 2023.
  • A 5-year view of Cost of Revenue shows it stood at $1734.0 in 2021, then changed by 0.0% to $1734.0 in 2022, then surged by 296.42% to $6874.0 in 2023, then grew by 7.01% to $7356.0 in 2024, then changed by 0.0% to $7356.0 in 2025.
  • Per Business Quant, the three most recent readings for CSUI's Cost of Revenue are $7356.0 (Q1 2025), $7356.0 (Q4 2024), and $7356.0 (Q3 2024).